非酒精性脂肪性肝病患者肝脏相关事件的即时无创预测
研究基于两个大型多中心队列(推导队列2638例NAFLD患者,验证队列679例更晚期患者),用Cox回归开发并验证基于肝硬度测量的3年肝脏相关事件风险预测模型。三种模型在推导队列区分度均高(c-statistic 0.87-0.91);验证队列中ANTICIPATE-NASH-LRE模型(0.81)优于ANTICIPATE-LRE模型(0.79),且校准良好(整合校准指数0.016)。
要点
- ANTICIPATE-LRE模型可个体化评估NAFLD/NASH患者3年肝脏相关事件风险。
- 验证队列中ANTICIPATE-NASH-LRE模型c-statistic为0.81,优于ANTICIPATE-LRE的0.79。
- ANTICIPATE-NASH-LRE模型在验证队列校准良好,整合校准指数为0.016。
核心结论
- ANTICIPATE-LRE模型、尤其是ANTICIPATE-NASH-LRE模型,可能成为经过验证的临床工具有效个体化评估NAFLD/NASH患者3年肝脏相关事件风险。
研究设计与样本
- 研究纳入两个大型多中心队列:推导队列为2638例覆盖所有肝硬度测量值的NAFLD患者,验证队列为679例更晚期患者。
- 采用Cox回归开发并验证基于肝硬度测量单独及基于ANTICIPATE和ANTICIPATE-NASH模型(针对临床显著门脉高压)的风险预测模型。
- 主要结局为初次评估后前3年肝脏相关事件发生率。
主要发现
- 推导队列中3种预测模型区分度均很高,c-statistic为0.87-0.91。
- 验证队列中肝硬度测量单独模型区分度(c-statistic 0.75)显著低于其他2种模型。
- 验证队列中ANTICIPATE-NASH-LRE模型(c-statistic 0.81)显著优于ANTICIPATE-LRE模型(0.79)。
- ANTICIPATE-NASH-LRE模型在验证队列校准良好,整合校准指数为0.016,且优于ANTICIPATE-LRE模型。
关键数值与推荐
- 推导队列中3种预测模型c-statistic为0.87-0.91。
- 验证队列中肝硬度测量单独模型c-statistic为0.75。
- 验证队列中ANTICIPATE-NASH-LRE模型c-statistic为0.81,ANTICIPATE-LRE模型为0.79。
- ANTICIPATE-NASH-LRE模型在验证队列的整合校准指数为0.016。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Individual risk prediction of liver-related events (LRE) is needed for clinical assessment of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients. We aimed to provide point-of-care validated liver stiffness measurement (LSM)-based risk prediction models for the development of LRE in patients with NAFLD, focusing on selecting patients for clinical trials at risk of clinical events. METHODS: Two large multicenter cohorts were evaluated, 2638 NAFLD patients covering all LSM values as the derivation cohort and 679 more advanced patients as the validation cohort. We used Cox regression to develop and validate risk prediction models based on LSM alone, and the ANTICIPATE and ANTICIPATE-NASH models for clinically significant portal hypertension. The main outcome of the study was the rate of LRE in the first 3 years after initial assessment. RESULTS: The 3 predictive models had similar performance in the derivation cohort with a very high discriminative value (c-statistic, 0.87-0.91). In the validation cohort, the LSM-LRE alone model had a significant inferior discrimination (c-statistic, 0.75) compared with the other 2 models, whereas the ANTICIPATE-NASH-LRE model (0.81) was significantly better than the ANTICIPATE-LRE model (0.79). In addition, the ANTICIPATE-NASH-LRE model presented very good calibration in the validation cohort (integrated calibration index, 0.016), and was better than the ANTICIPATE-LRE model. CONCLUSIONS: The ANTICIPATE-LRE models, and especially the ANTICIPATE-NASH-LRE model, could be valuable validated clinical tools to individually assess the risk of LRE at 3 years in patients with NAFLD/NASH.
引用
- Pons M, Rivera-Esteban J, Ma MM, et al. Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023. PMID: 37573987. doi:10.1016/j.cgh.2023.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。